Antibody News and Press Releases

How to save your pharma R&D projects?

European Business Conferences Group (EBCG)

08/01/2014

The pharmaceutical industry is in great danger with the productivity of research and development rapidly decreasing as well as many major drug patents expiring in the upcoming years. It is high time to take action and receive valuable strategic and operational insights into the latest trends in the industry. At the Pharma PPM Toolbox 2014, which will take place in Zürich, Switzerland from the 19th - 21st March 2014, you will find out the answers also to these...

Ready-to-Use Stable Cell Lines

AMS Biotechnology (AMSBIO)

02/01/2014

AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. Using AMSBIO stable cell lines not only provides an optimized solution for manufacture of therapeutic and diagnostic protein, but also for applications in drug screening, pharmacological research and toxicological studies.The extensive portfolio of ready-to-use stable cell lines...

Creative Biomart Launches New Range of Biosimilar Cell Line Products for Biopharmaceutical Segment

Creative Biomart

18/12/2013

Creative Biomart, a US-based biotechnology company providing technologies and services for the rapid development of high-performance stable cell lines has launched an expanded offering that focuses on the biosimilar cell lines. Creative Biomart scientists developed the biosimilar stable cell lines with its proprietary gene screening and amplification system that combines its unique technique platforms and its cell culture know-how for the rapid development of biosimilars...

Problems in Recombinant Protein Production and Strategies for Solutions

Creative Biomart

29/11/2013

Right before the Thanksgiving Holiday, Creative Biomart hosted a web seminar to discuss common problems in recombinant protein production and strategies for solutions. The web-seminar lasted for 40mins. During the webinar, the main host, Dr. J, the scientific officer of Creative Biomart led the participants (including researchers, students, partners, customers etc.) to review the common challenges with recombinant protein production from different hosts, the culture...

Abcam Introduces Alexa Fluor Secondary Antibodies

04/11/2013

New range offers increased choice for multi-colour stainingCambridge, UK, November 04 2013: Abcam Plc., a leading provider of protein research tools and services, announced today that it has added new Alexa Fluor® 405/568/750 conjugated secondary antibodies to its existing Alexa Fluor® 488/555/594/647 conjugates. Extensively tested in Abcam’s labs, the Alexa Fluor range guarantees bright staining and low background. The different colour variants were selected...

Animal-Free and Endotoxin-Free Stem Cell Factors

AMS Biotechnology (AMSBIO)

15/10/2013

A new range of animal-free and endotoxin-free growth factors and cytokines, tailored to stem cell research, has been launched by AMSBIO – a leading supplier of recombinant proteins.The success of stem cell research depends on the development of optimal cell culture systems. Both expansion and differentiation of stem cells is highly reliant on growth factor and cytokine supplements, with the activity and purity of these recombinants being critical to successful...

NEW Application of TAP’s ambr Microscale Bioreactor as Perfusion Mimic Offers Rapid Method Development of Large Scale Perfusion Culture Processes

TAP Biosystems

15/10/2013

Cambridge, UK: TAP Biosystems, a leading supplier of innovative cell culture and consumables for life science, today announced a new application of its ambr™ micro bioreactor system as a perfusion mimic, enabling scientists to rapidly and easily develop large scale perfusion culture processes of unstable, low producing or minimally expressing proteins or antibodies.The ambr system has been utilised as a semi-continuous chemostat model for perfusion culture in 10-15mL...

Abcam Named AIM Company of the Year

Abcam

14/10/2013

Award celebrates achievements of a dynamic business with strong future growth prospectsCambridge UK, October 14, 2013: Abcam Plc., a leading provider of life science research tools, announced today it has been named ‘Company of the Year’ in the 2013 AIM Awards. The AIM awards celebrate outstanding achievement of quoted companies and entrepreneurs who have harnessed AIM to help them fulfil their ambition and growth potential in the last twelve months.Company of...

NEW from MBS R&D, Monoclonal Antibodies to Cystatin C

Maine Biotechnology Services

17/09/2013

MBS is pleased to release three new monoclonal antibodies to Cystatin C, available in two matched pair combinations. The pairs have proven sensitive enough to detect Cystatin C present in serum and purified from urine in the ng/mL range. As always, these antibodies were developed and produced at MBS to allow for extensive product support and maximum price flexibility for bulk sales.

Abcam Launches SimpleStep ELISA Kits

Abcam

09/09/2013

Kits offer enhanced performance and ease of use to accelerate immunoassay researchCambridge, UK, September 09 2013: Abcam plc., a producer and distributor of high quality protein research tools, announced today that it has launched a range of SimpleStep™ ELISA kits. The new kits have a greatly simplified protocol when compared to standard multi-step ELISAs, providing significant time savings and ease of use. Offering enhanced performance, SimpleStep ELISA kits are...